Association of endothelial dysfunction with sulfur amino acid metabolism in chronic renal failure

American Journal of Kidney Diseases

Volumn 38, Issue 4 SUPPL. 1, 2001, Pages

  Takamitsu, Y ^a   Nakanishi, T ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Chronic renal failure (CRF); Endothelial function; Hyperhomocysteinemia

Indexed keywords

NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SULFUR AMINO ACID;

ADULT; AGED; AMINO ACID METABOLISM; AUTOOXIDATION; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONFERENCE PAPER; ENDOTHELIUM LESION; FEMALE; GLUCOSE INTOLERANCE; HEMODIALYSIS; HEMOSTASIS; HUMAN; HYPEREMIA; HYPERHOMOCYSTEINEMIA; MALE; MUSCLE FUNCTION; PERITONEAL DIALYSIS; SIGNAL TRANSDUCTION; UREMIA;

EID: 0034809816     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2001.27413     Document Type: Conference Paper

References (20)

1. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations
2. The pathogenesis of atherosclerosis: A perspective for 1990s
3. Homocysteine-mediated endothelial cell toxicity and its amelioration
4. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans
5. Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis
6. Endothelium-dependent vasodilation and distensibility of large arteries in chronic haemodialysis patients
7. Vascular dysfunction in monkeys with diet-induced hyperhomocys(e)inemia
8. Homocys(e)ine and risk of cardiovascular disease in the multiple risk factor intervention trial
9. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine
10. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase
11. Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications
12. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease
13. Large coronary arteries in human are responsive to changing blood flow: An endothelium-dependent mechanism that fails in patients with atherosclerosis
14. Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients
15. Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?
16. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus
17. No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients
18. Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: No change in endothelial function after long-term therapy
19. Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: Is homocyst(e)ine the missing link?
20. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?